She is a co-investigator in the NIH Undiagnosed Diseases program targeting the discovery of new IEMs and the further characterization of rare presentations of previously identified disorders. She is a member of the faculty for the North American Metabolic Academy (NAMA) established by the Society of Inherited Metabolic Disorders and instructs in the areas of glycosylation disorders among others.